ATE433485T1 - Chemisch modifizierte mutante serinhydrolasen - Google Patents

Chemisch modifizierte mutante serinhydrolasen

Info

Publication number
ATE433485T1
ATE433485T1 AT99964973T AT99964973T ATE433485T1 AT E433485 T1 ATE433485 T1 AT E433485T1 AT 99964973 T AT99964973 T AT 99964973T AT 99964973 T AT99964973 T AT 99964973T AT E433485 T1 ATE433485 T1 AT E433485T1
Authority
AT
Austria
Prior art keywords
cysteine
serine hydrolases
chemically modified
group
modified
Prior art date
Application number
AT99964973T
Other languages
English (en)
Inventor
John Jones
Michael Dickman
Original Assignee
Univ Toronto
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Toronto filed Critical Univ Toronto
Application granted granted Critical
Publication of ATE433485T1 publication Critical patent/ATE433485T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/52Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea
    • C12N9/54Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea bacteria being Bacillus

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT99964973T 1998-11-10 1999-11-09 Chemisch modifizierte mutante serinhydrolasen ATE433485T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10775898P 1998-11-10 1998-11-10
US11306198P 1998-12-21 1998-12-21
PCT/US1999/026586 WO2000028007A2 (en) 1998-11-10 1999-11-09 Chemically modified mutant serine hydrolases

Publications (1)

Publication Number Publication Date
ATE433485T1 true ATE433485T1 (de) 2009-06-15

Family

ID=26805118

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99964973T ATE433485T1 (de) 1998-11-10 1999-11-09 Chemisch modifizierte mutante serinhydrolasen

Country Status (9)

Country Link
US (4) US20050282248A1 (de)
EP (1) EP1129180B1 (de)
JP (1) JP4932990B2 (de)
AT (1) ATE433485T1 (de)
AU (1) AU772427B2 (de)
CA (1) CA2348014A1 (de)
DE (1) DE69940978D1 (de)
DK (1) DK1129180T3 (de)
WO (1) WO2000028007A2 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6908757B1 (en) 1998-03-26 2005-06-21 The Procter & Gamble Company Serine protease variants having amino acid deletions and substitutions
US6495136B1 (en) 1998-03-26 2002-12-17 The Procter & Gamble Company Proteases having modified amino acid sequences conjugated to addition moieties
US6569663B1 (en) 1998-03-26 2003-05-27 The Procter & Gamble Company Serine protease variants having amino acid substitutions
WO2000028007A2 (en) 1998-11-10 2000-05-18 Genencor International, Inc. Chemically modified mutant serine hydrolases
EP1185302B1 (de) * 1999-04-28 2013-07-24 Genencor International, Inc. Spezifischer zielrichtung von katalytische antagoniste und deren verwendungen
BR0012660A (pt) 1999-07-22 2002-04-09 Procter & Gamble Variante de protease tipo subtilisina; composição de limpeza; e composição de cuidado pessoal
US6946128B1 (en) 1999-07-22 2005-09-20 The Procter & Gamble Company Protease conjugates having sterically protected epitope regions
CN1373802A (zh) 1999-07-22 2002-10-09 宝洁公司 在特定表位区域具有氨基酸缺失和取代的枯草杆菌蛋白酶变体
EP1196547A2 (de) * 1999-07-22 2002-04-17 The Procter & Gamble Company Proteasekonjugate mit sterisch geschützten epitopgebieten
MXPA02000842A (es) 1999-07-22 2002-07-30 Procter & Gamble Conjugados de proteasa que tienen sitios de corte protegidos estericamente.
US7202070B2 (en) * 2000-10-31 2007-04-10 Biocatalytics, Inc. Method for reductive amination of a ketone using a mutated enzyme
DE10121463A1 (de) * 2001-05-02 2003-02-27 Henkel Kgaa Neue Alkalische Protease-Varianten und Wasch- und Reinigungsmittel enthaltend diese neuen Alkalischen Protease-Varianten
EP1354960A1 (de) * 2002-04-08 2003-10-22 Degussa AG Verfahren zur Bestimmung der Syntheseaktivität von Hydrolasen
EP1359225B1 (de) * 2002-04-08 2006-11-15 Degussa AG Verfahren zur Bestimmung der Syntheseaktivität von Hydrolasen
EP3307848B1 (de) 2015-06-10 2019-03-06 Merck Patent GmbH Chirale dotierstoffe mit nortricyclan-einheit

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5155033A (en) 1989-01-06 1992-10-13 Genencor, Inc. Subtilisins modified at position 225 resulting in a shift in catalytic activity
US5972682A (en) 1984-05-29 1999-10-26 Genencor International, Inc. Enzymatically active modified subtilisins
US5244791A (en) 1984-05-29 1993-09-14 Genecor International, Inc. Methods of ester hydrolysis
CN1056187C (zh) 1988-02-11 2000-09-06 金克克国际有限公司 新的蛋白水解酶及其在洗涤剂中的应用
US5116741A (en) * 1988-04-12 1992-05-26 Genex Corporation Biosynthetic uses of thermostable proteases
DK97190D0 (da) 1990-04-19 1990-04-19 Novo Nordisk As Oxidationsstabile detergentenzymer
EP0542931B1 (de) 1990-08-09 1999-12-08 Genentech, Inc. Serinproteasevarianten mit peptidligase aktivität
US5629173A (en) * 1990-08-09 1997-05-13 Genentech, Inc. Methods of use of serine protease variants having peptide ligase activity
US5316935A (en) * 1992-04-06 1994-05-31 California Institute Of Technology Subtilisin variants suitable for hydrolysis and synthesis in organic media
US5837516A (en) 1995-03-03 1998-11-17 Genentech, Inc. Subtilisin variants capable of cleaving substrates containing basic residues
US6946280B1 (en) 1996-03-29 2005-09-20 Genencor International, Inc. Enzyme multimer and process of producing same
CN1246146A (zh) * 1996-11-26 2000-03-01 金克克国际有限公司 化学修饰的酶
AR015977A1 (es) 1997-10-23 2001-05-30 Genencor Int Variantes de proteasa multiplemente substituida con carga neta alterada para su empleo en detergentes
EP1064019B1 (de) * 1998-01-23 2010-11-03 The Governing Council Of The University Of Toronto Chemisch modifizierte enzyme und methoden zu ihrer herstellung und zum screeningder enzyme
US6395532B1 (en) * 1998-01-23 2002-05-28 Genencor International, Inc. Modified enzymes and their use for peptide synthesis
DE69939538D1 (de) * 1998-07-02 2008-10-23 Univ Toronto Mit einer kohlenhydratgruppe chemisch modifizierte proteine
WO2000028007A2 (en) 1998-11-10 2000-05-18 Genencor International, Inc. Chemically modified mutant serine hydrolases
AU2200100A (en) * 1998-12-21 2000-07-12 Genencor International, Inc. Chemically modified enzymes with multiple charged variants

Also Published As

Publication number Publication date
US20120156721A1 (en) 2012-06-21
CA2348014A1 (en) 2000-05-18
US8357524B2 (en) 2013-01-22
AU3099000A (en) 2000-05-29
JP2002529078A (ja) 2002-09-10
AU772427B2 (en) 2004-04-29
DE69940978D1 (de) 2009-07-23
JP4932990B2 (ja) 2012-05-16
US20090075329A1 (en) 2009-03-19
US8148128B2 (en) 2012-04-03
EP1129180A2 (de) 2001-09-05
DK1129180T3 (da) 2009-08-24
US20120295329A1 (en) 2012-11-22
US20050282248A1 (en) 2005-12-22
EP1129180B1 (de) 2009-06-10
WO2000028007A3 (en) 2000-07-27
WO2000028007A2 (en) 2000-05-18

Similar Documents

Publication Publication Date Title
DE69940978D1 (de) Chemisch modifizierte mutante serinhydrolasen
BR9908280A (pt) Inibidores de enzimas de fosfolipase
DE60131262D1 (en) Ubiquitin-ligase-assay
WO2003103613A3 (en) Induction of insulin expression
IL128221A (en) Cell adhesion inhibitors
TR200003071T2 (tr) Sistein-proteazı önleyici etkiye sahip yeni heterosiklik ikame edilmiş amidler
TR199901191T2 (xx) Benzamidoaldehitlerin sistein proteaz� inhibit�r� olarak kullan�m�.
AU7417398A (en) Chemically modified enzymes
WO2003006652A3 (en) Inhibition of specific histone deacetylase isoforms
TR199902728T2 (xx) Kuinolat fosforibosil transferaz ekspresyonunun d�zenlenmesi.
BR0115361A (pt) Método de estabilizar hidrogéis de silicone contra a degradação hidrolìtica
BR0011030A (pt) Composições de cicloporina substancialmente livre de óleo
DE69433015D1 (de) Neue Enzyme und Prodrugs für ADEPT
EP0975353A4 (de) Peptidyl-2-amino-1hydroxyalkansulfonsäuren als cystein-protease-inhibitoren
AU2002304335A1 (en) Culture medium for enhanced heterologous protein expression
NO975188L (no) Anvendelse av mannanaser som slimregulerende midler
AR001732A1 (es) Celulasa alcalina novedosa y método para producirla
IL138688A0 (en) Certain heteroaryl substituted thiol inhibitors of endothelin-converting enzyme
DE69820082D1 (de) Durch-schnappende dichtung für galvanische zelle
GB0115382D0 (en) Mutant
NO20003880D0 (no) Transfekterende midler som er sensitive overfor reduserende betingelser, farmasøytiske preparater inneholdende disse samt deres anvendelser
AR030593A1 (es) Sistema tensioactivo
AU2003287945A8 (en) Mutant protein and refolding method
WO2002086092A3 (en) N-methyltransferase
ATE311441T1 (de) Acrylamidase-enzyme

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties